By Ajay ji
“Glenmark Pharma stock has recently reversed from an 8-month-long corrective phase, accompanied by a noticeable surge in volumes. Traders can buy for a target of Rs 1940 in the next 2-4 months,” Ajit Mishra – SVP, Research, Religare Broking Ltd, said
Show more
WhatsApp Group Join Now Telegram Group Join Now Instagram Group Join Now The European Central Bank’s inflation target…
ByAjay jiWhatsApp Group Join Now Telegram Group Join Now Instagram Group Join Now Why the Interest Coverage Ratio Matters…
ByAjay jiWhatsApp Group Join Now Telegram Group Join Now Instagram Group Join Now Markets remained under pressure and ended…
ByAjay jiWhatsApp Group Join Now Telegram Group Join Now Instagram Group Join Now An attempt to break out of…
ByAjay ji
